Browse by Disease Classification

This page shows data for Exanthous Disease Classification.
Total Entries Retrieved: 77
IDVaccine NameDisease NameDisease ClassificationVirus NameNucleic Acid ContentVaccine TypeVaccine StatusManufacturerYear of ManufacturingManufacturing CountryAgeDosageAdministration RouteAdjuvantTarget StrainDescriptionApproving OrganisationCollaborating OrganisationOther CountriesTrade NamePMIDClinical Trial IDReference LinkAdditional Links
10131 ACAM2000 Smallpox Exanthous Variola virus double stranded DNA Live-attenuated Approved Emergent BioSolutions 2003 USA Below 12 months of age Single dose Percutaneous NA Recombinant vaccinia viruses derived from replication-competent vaccinia strain Lyophilized US FDA NA NA NA NA NA https://www.fda.gov/vaccines-blood-biologics/vaccines/acam2000 NA
10132 JYNNEOS Smallpox Exanthous Variola virus double stranded DNA Live-attenuated Approved Bavarian Nordic NA Denmark 18 years and above 2 doses 4 weeks apart Subcutaneous NA Vaccinia Virus Ankar NA US FDA NA NA Imvamune, Imvanex, MVA-BN NA NA https://www.fda.gov/vaccines-blood-biologics/jynneos https://www.fda.gov/media/131078/download
10133 Aventis Pasteur Smallpox Vaccine Smallpox Exanthous Variola virus double stranded DNA Live-attenuated Approved National Institute of Allergy and Infectious Diseases 2010 USA 18 - 32 years NA Percutaneous NA NA NA US FDA NA NA NA NA NCT00038987 https://www.fda.gov/emergency-preparedness-and-response/mcm-issues/smallpox-preparedness-and-response-updates-fda https://clinicaltrials.gov/ct2/show/NCT00038987
10134 Priorix Measles, Mumps, Rubella, Chickenpox Exanthous Morbillivirus, Mumps virus, Rubella virus, Varicella-zoster virus negative-sense, single-stranded RNA Live-attenuated Approved GlaxoSmithKline 2019 NA 11 months - 22 months 2 doses 42 days apart Subcutaneous NA Vaccinia Virus NA NA NA NA NA NA NCT00226499 https://www.fda.gov/vaccines-blood-biologics/priorix https://clinicaltrials.gov/ct2/show/NCT00226499
10135 Varivax Chickenpox Exanthous Varicella-zoster virus double stranded DNA Live-attenuated Approved Merck & Co. Inc. 2007 USA 1 - 12 years 2 doses (0.5 ml each) separated by at least 3 months.# First dose: age 12 through 15 months, Second dose: age 4 through 6 years Subcutaneous NA Oka/Merck strain of live-attenuated varicella virus NA US FDA NA NA NA NA NCT00822237 https://www.cdc.gov/vaccines/vpd/varicella/index.html https://www.fda.gov/vaccines-blood-biologics/vaccines/varivax
10136 Varivax Chickenpox Exanthous Varicella-zoster virus double stranded DNA Live-attenuated Approved Merck & Co. Inc. 2007 USA 12 - 23 months 2 doses 4 weeks apart Subcutaneous NA Oka/Merck strain of live-attenuated varicella virus NA US FDA NA NA NA NA NA https://www.cdc.gov/vaccines/vpd/varicella/index.html https://www.fda.gov/vaccines-blood-biologics/vaccines/varivax
10137 ProQuad Measles, Mumps, Rubella, Varicella Exanthous Morbillivirus, Mumps virus, Rubella virus, Varicella-zoster virus negative-sense, single-stranded RNA Live-attenuated Approved Merck & Co. Inc. NA USA 1 - 12 years First dose at 12 through 15 months of age and Second dose at 4 through 6 years of age Subcutaneous NA NA NA US FDA NA NA NA NA NCT00985166 https://www.cdc.gov/vaccines/vpd/varicella/index.html https://www.fda.gov/vaccines-blood-biologics/vaccines/proquad
10214 RH-CHIKV EV-CHIKV RHEV-CHIKV Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Phase 1 NA NA NA NA Single dose Footpad injection NA R532H-nsP, E515V-nsP2 NA NA NA NA NA 31921059 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930866/ NA
10215 Delta 5nsP3 DREP-E MVA-CE Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Phase 1 NA NA NA NA Single dose Subcutaneous NA CHIKV nsP3 envelope and capsid protein NA NA NA NA NA 31921059 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930866/ NA
10216 Ad-CHIKV-SG Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Virus like particle Phase 1 NA NA NA NA Single dose Intranasal NA CHIKV structural proteins NA NA NA NA Ad-CHIKV-E3/E2/6K, Ad-CHIKV-E3/E2/E1 31921059 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930866/ NA
10217 ChAdOx1-sCHIKV Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Virus like particle Phase 1 NA NA NA NA Single dose Intramuscular NA CHIKV structural proteins NA NA NA NA NA 31921059 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930866/ NA
10218 VSV G-CHIKV Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Virus like particle Phase 1 NA NA NA NA Single dose Intramuscular NA CHIKV envelope proteins (E1, E2, and E3) NA NA NA NA NA 31921059 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930866/ NA
10219 dMAb Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA DNA based vaccine Phase 1 NA NA NA NA NA Intramuscular NA CHIKV envelope proteins (E1, E2, and E3) NA NA NA NA NA 31921059 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930866/ NA
10220 pCHIKV-7 Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA DNA based vaccine Phase 1 NA NA NA NA NA NA NA cDNA of 181/25 NA NA NA NA NA 31921059 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930866/ NA
10221 CHKV-24 Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA RNA based vaccine Phase 1 NA NA NA NA Single dose Intravenous NA NA NA NA NA NA NA 31921059 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930866/ NA
10222 VRC-CHKVLP059-00-VP Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Virus like particle Phase 1 National Institute of Health 2016 USA 18 - 50 years 10 ug at weeks 0, 4, and 20 Intramuscular NA Human HEK293 cells NA NA National Institute of Allergy and Infectious Diseases NA NA NA NCT01489358 https://clinicaltrials.gov/ct2/show/NCT01489358 NA
10223 USAMRIID Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Phase 1 NA NA NA NA 1- 2 doses depending on volume and age NA NA NA Formalin inactivated produced in green monkey kidney cells or chick embryonic cells NA NA NA NA NA NA https://academic.oup.com/jid/article/214/suppl_5/S488/2632628 NA
10224 VLP- NIH Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Virus like particle Phase 1 NA NA NA NA 3 doses NA NA NA Produced from DNA transfected into human embryonic kidney VRC293 NA NA NA NA NA NA https://academic.oup.com/jid/article/214/suppl_5/S488/2632628 NA
10225 Measles-CHIKV Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Phase 1 NA NA NA NA Single dose NA NA CHIKV proteins Recombinant measles virus (Schwartz strain) expressing CHIKV VLPs NA NA NA NA NA NA https://academic.oup.com/jid/article/214/suppl_5/S488/2632628 NA
10226 TSI-GSD-218 Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Phase 1 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA https://link.springer.com/chapter/10.1007/82_2019_175 NA
10227 CHIKV Delta 5nsP3 Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Phase 1 NA NA NA NA NA NA NA Clinical strain attenuated by targeted mutations in nsP3, 6 K NA NA NA NA NA NA NA https://link.springer.com/chapter/10.1007/82_2019_175 NA
10228 CHIK001 Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Recombinant viral vector Phase 1 University of Oxford 2019 NA 18 - 50 years NA NA NA Chimpanzee adenovirus expressing CHIKV structural proteins NA NA NA NA NA NA NCT03590392 https://link.springer.com/chapter/10.1007/82_2019_175 https://clinicaltrials.gov/ct2/show/NCT03590392?cond=Chickungunya+Fever&draw=2&rank=29
10229 mRNA-1944 Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA RNA based vaccine Phase 1 Moderna Inc. 2021 USA 18 - 50 years NA NA NA CHIKV-directed monoclonal antibody NA US FDA Defense Advanced Research Projects Agency NA NA NA NCT03829384 https://link.springer.com/chapter/10.1007/82_2019_175 https://clinicaltrials.gov/ct2/show/NCT03829384
10230 mRNA-1388 Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA RNA based vaccine Phase 1 Moderna Inc. 2017 USA 18 - 49 years 3 doses on week 0, week 4, post 1 year Intramuscular NA CHIKV structural proteins mRNA based vaccine NA Defense Advanced Research Projects Agency NA NA NA NA https://link.springer.com/chapter/10.1007/82_2019_175 https://www.modernatx.com/pipeline/mrna-1388
10231 VLA1533 Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Recombinant viral vector Phase 1 Valneva 2019 Austria 18 - 39 years 3 doses on day 0, 28 and 56 Intramuscular NA NA NA NA NA NA NA NA NCT03010228 https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0006919 https://clinicaltrials.gov/ct2/show/NCT03010228
10232 VAL-181388 Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA RNA based vaccine Phase 1 Moderna Inc. 2017 USA 18 - 49 years 3 doses on week 0, week 4, post 1 year NA NA NA NA US FDA Defense Advanced Research Projects Agency NA NA NA NCT03325075 https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0006919 https://clinicaltrials.gov/ct2/show/NCT03325075
10233 IRES-CHIKV Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Phase 1 University of Texas Medical Branch, Takeda Pharmaceutical Company Limited 2011 USA NA NA Subcutaneous NA La Reunion strain NA NA NA NA NA NA NA https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0006919 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145802/
10234 EILV/CHIKV Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Virus like particle Phase 1 University of Texas Medical Branch 2017 USA NA NA NA NA CHIKV structural proteins NA NA NA NA NA NA NA https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0006919 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5296253/
10298 CHIKV-NoLS Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Phase 2 NA NA NA NA Single dose Subcutaneous NA N-terminal region of capsid protein NA NA NA NA NA 31921059 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930866/ NA
10299 MV-CHIK Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Virus like particle Phase 2 NA NA NA NA 0.35 mL single measle vaccine dose, twice injection at day 0 and day 28 Intramuscular NA Measles-vectored CHIKV structural proteins NA NA NA NA NA 31921059 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930866/ NA
10300 EILV/CHIKV Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Virus like particle Phase 2 NA NA NA NA 8.8 log10 PFU (C57BL/6) or 8.5 log10 PFU (IFN?/?R–/–mice) of live EILV/CHIKV, single injection Subcutaneous NA EILV cDNA clone containing CHIKV structural proteins NA NA NA NA NA 31921059 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930866/ NA
10301 CHIK-VLP Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Virus like particle Phase 2 NA NA NA NA Single dose Intramuscular NA C-E proteins NA NA NA NA NA 31921059 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930866/ NA
10302 CHIK-VLP Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Virus like particle Phase 2 NA NA NA NA NA Subcutaneous NA CHIKV structural proteins introduced into yeast expression system NA NA NA NA NA 31921059 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930866/ NA
10303 MV-CHIK Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Phase 2 Themis Bioscience 2021 USA 21 - 65 years 2 doses 28 days apart Intramuscular NA NA NA US FDA Walter Reed Army Institute of Research NA NA NA NCT03807843 https://clinicaltrials.gov/ct2/show/NCT03807843 NA
10304 TSI-GSD-218 Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Phase 2 NA NA NA NA Single dose NA NA NA Attenuation by serial, plaque-to-plaque MRC5 cell passages NA NA NA NA NA NA https://academic.oup.com/jid/article/214/suppl_5/S488/2632628 NA
10305 MV/Schwarz Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Recombinant viral vector Phase 2 NA NA NA NA NA NA NA CHIKV structural proteins NA NA NA NA NA NA NA https://link.springer.com/chapter/10.1007/82_2019_175 NA
10306 CHIK-VLP Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Virus like particle Phase 2 Emergent BioSolutions 2020 USA 18 - 45 years 2 doses on day 0, 29 Parenteral or mucosal route Alhydrogel CHIKV structural proteins (C, E3, E2, 6K, E1) NA US FDA National Institute of Health, PaxVax NA NA NA NCT03483961 https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0006919 https://clinicaltrials.gov/ct2/show/NCT03483961
10307 MV-CHIKV Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Phase 2 Institut Pasteur of Shanghai, Themis Bioscience 2021 NA 18 - 55 years 3 doses on day 0, 28 and 196 Intramuscular NA NA NA NA NA NA NA NA NCT02861586 https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0006919 https://clinicaltrials.gov/ct2/show/NCT02861586
10308 MVA-mBN85B Measles Exanthous Morbillivirus negative-sense, single-stranded RNA Recombinant viral vector Phase 2 Bavarian Nordic 2012 South Africa 6 months - 6 years 2 doses 4 weeks apart Subcutaneous NA Attenuated Modified Vaccinia Virus Ankara, strain encoding hemagglutinin protein, fusion protein and nucleoprotein of measles virus NA NA NA NA Rouvax NA NCT00891007 https://clinicaltrials.gov/ct2/show/NCT00891007?recrs=abde&cond=measles+vaccines&phase=123&draw=2&rank=3 NA
10309 MeMuRu-OKA Measles, Mumps, Rubella, Varicella Exanthous Morbillivirus, Mumps virus, Rubella virus, Varicella-zoster virus negative-sense, single-stranded RNA Live-attenuated Phase 2 GlaxoSmithKline 2016 Canada 15 months - 6 years NA Subcutaneous NA Jeryl Lynn strain, Schwarz strain, RA 27/3 strain, OKA strain NA NA NA NA NA NA NCT00352898 https://clinicaltrials.gov/ct2/show/NCT00352898 https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-006065-14/DE
10372 Sf21-VLP (PXVX0317) Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Virus like particle Phase 3 Emergent BioSolutions 2021 NA 12 - 65 years NA NA Alhydrogel NA Virus-like particle made using baculovirus and Sf21 insect cells US FDA NA NA NA NA NCT05072080 https://link.springer.com/chapter/10.1007/82_2019_175 https://clinicaltrials.gov/ct2/show/NCT05072080
10373 PENN CHIKV-2008 (PC-08) Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA DNA based vaccine Phase 3 University of Pennsylvania 2011 USA NA NA NA NA CHIKV envelope proteins (E1, E2, and E3) NA NA NA NA NA NA NA https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0006919 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3019110/
10374 MRVAC Measles, Rubella Exanthous Morbillivirus, Rubella virus negative-sense, single-stranded RNA Live-attenuated Phase 3 Center for Research and Production of Vaccines and Biologicals 2018 Vietnam 1 - 45 years NA Subcutaneous NA Strain AIK-C measles virus clone with Takahashi rubella virus NA NA NA NA NA NA NCT03713359 https://clinicaltrials.gov/ct2/show/NCT03713359?recrs=abde&cond=measles+vaccines&phase=123&draw=2&rank=54 NA
10385 DeltaC-CHIKV Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Preclinical NA NA NA NA Single dose Subcutaneous NA Capsid deletion NA NA NA NA NA 31921059 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930866/ NA
10386 Stop CHIKV SuperStop CHIKV Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Preclinical NA NA NA NA Single dose Footpad injection NA NA NA NA NA NA NA 31921059 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930866/ NA
10387 DRDE-06 Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Preclinical NA NA NA NA 3 doses NA NA NA Formalin inactivated produced in vero cells NA NA NA NA NA NA https://academic.oup.com/jid/article/214/suppl_5/S488/2632628 NA
10388 CHIK-E1/E2 Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Subunit vaccine Preclinical NA NA NA NA 3 doses NA NA E1/E2 Recombinant E1/E2 produced in E. coli NA NA NA NA NA NA https://academic.oup.com/jid/article/214/suppl_5/S488/2632628 NA
10389 CHIK-E2 Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Subunit vaccine Preclinical NA NA NA NA 2 doses NA NA E1 Recombinant E2 produced in E. coli NA NA NA NA NA NA https://academic.oup.com/jid/article/214/suppl_5/S488/2632628 NA
10390 VLP-CHIKV-S27 Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Virus like particle Preclinical NA NA NA NA 2 doses NA NA CHIKV proteins Baculovirus-vectored CHIKV VLPs formulated with adjuvant NA NA NA NA NA NA https://academic.oup.com/jid/article/214/suppl_5/S488/2632628 NA
10391 Chimeric alphavirus Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Preclinical NA NA NA NA Single dose NA NA CHIKV structural proteins Recombinant alphavirus (EEEV, VEEV, SINV) with CHIKV structural proteins NA NA NA NA NA NA https://academic.oup.com/jid/article/214/suppl_5/S488/2632628 NA
10392 CHIKV/IRES Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Preclinical NA NA NA NA Single dose NA NA CHIKV structural proteins NA NA NA NA NA NA NA https://academic.oup.com/jid/article/214/suppl_5/S488/2632628 NA
10393 VSV-CHIKV Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Preclinical NA NA NA NA Single dose NA NA CHIKV structural proteins NA NA NA NA NA NA NA https://academic.oup.com/jid/article/214/suppl_5/S488/2632628 NA
10394 CAdVax-CHIK Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Recombinant viral vector Preclinical GenPhar Inc. NA NA NA Single dose NA NA CHIKV structural proteins Produced in HEK293 packaging cell line NA NA NA NA NA NA https://academic.oup.com/jid/article/214/suppl_5/S488/2632628 https://www.sciencedirect.com/science/article/pii/S0264410X16300731
10395 MVA-CHIKV Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Recombinant viral vector Preclinical NA NA NA NA Single dose NA NA CHIKV structural proteins NA NA NA NA NA NA NA https://academic.oup.com/jid/article/214/suppl_5/S488/2632628 NA
10396 pMCE321 Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA DNA based vaccine Preclinical NA NA NA NA NA Intramuscular NA Sequence of E3, E2, and E1 genes under a CMV promoter NA NA NA NA NA NA NA https://academic.oup.com/jid/article/214/suppl_5/S488/2632628 NA
10397 iDNA Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA DNA based vaccine Preclinical NA NA NA NA NA Intramuscular NA CHIKV strain 181/25 NA NA NA NA NA NA NA https://academic.oup.com/jid/article/214/suppl_5/S488/2632628 NA
10398 DREP-Env Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA DNA based vaccine Preclinical NA NA NA NA NA Intradermal NA CHIKV replicon (nsP1 to nsP4) and CHIKV envelope proteins (E1, E2, and E3) NA NA NA NA NA NA NA https://academic.oup.com/jid/article/214/suppl_5/S488/2632628 NA
10399 LR-E2-E79 K Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Preclinical NA NA NA NA NA NA NA Clinical strain LR attenuated by mutations in heparin sulfate binding domains NA NA NA NA NA NA NA https://link.springer.com/chapter/10.1007/82_2019_175 NA
10400 CHIKV TM17-2 Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Preclinical NA NA NA NA NA NA NA Clinical strain attenuated by mutations in E2 transmembrane domain NA NA NA NA NA NA NA https://link.springer.com/chapter/10.1007/82_2019_175 NA
10401 CHIKV/IRES Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Preclinical NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA https://link.springer.com/chapter/10.1007/82_2019_175 NA
10402 VSVdelG-CHIKV Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Recombinant viral vector Preclinical NA NA NA NA NA NA NA Glycoprotein-deficient VSV encoding CHIKV structural proteins NA NA NA NA NA NA NA https://link.springer.com/chapter/10.1007/82_2019_175 NA
10403 VEE/CHIKV Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Recombinant viral vector Preclinical NA NA NA NA NA NA NA Chimera consisting of VEEV nsP and CHIKV structural proteins NA NA NA NA VEE/IRES-C/CHIKV NA NA https://link.springer.com/chapter/10.1007/82_2019_175 NA
10404 EILV/CHIKV Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Recombinant viral vector Preclinical NA NA NA NA NA NA NA Eilat virus nonstructural and CHIKV structural proteins NA NA NA NA NA NA NA https://link.springer.com/chapter/10.1007/82_2019_175 NA
10405 CAdVax-CHIK Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Recombinant viral vector Preclinical NA NA NA NA NA NA NA Replication-deficient Ad5 encoding CHIKV structural proteins NA NA NA NA NA NA NA https://link.springer.com/chapter/10.1007/82_2019_175 NA
10406 MVA-6KE1E3E2 Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Recombinant viral vector Preclinical NA NA NA NA NA NA NA MVA encoding CHIKV structural proteins NA NA NA NA NA NA NA https://link.springer.com/chapter/10.1007/82_2019_175 NA
10407 MVA-E2E3 Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Recombinant viral vector Preclinical NA NA NA NA NA NA NA CHIKV envelope protein (E2, E3) NA NA NA NA NA NA NA https://link.springer.com/chapter/10.1007/82_2019_175 NA
10408 MVA-CHIKV Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Recombinant viral vector Preclinical NA NA NA NA NA Intraperitoneal NA CHIKV structural proteins (C, E3, E2, 6K, E1) into MVA NA NA NA NA NA NA NA https://link.springer.com/chapter/10.1007/82_2019_175 NA
10409 UV-CHIKV Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Inactivated Preclinical NA NA NA NA NA NA NA CHIKV proteins Inactivated by UV-irradiation NA NA NA NA NA NA https://link.springer.com/chapter/10.1007/82_2019_175 NA
10410 BEI-CHIKV Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Inactivated Preclinical NA NA NA NA NA NA NA CHIKV proteins Inactivated by binary ethyleneimine NA NA NA NA NA NA https://link.springer.com/chapter/10.1007/82_2019_175 NA
10411 Formalin-inactivated CHIKV Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Inactivated Preclinical NA NA NA NA NA NA NA CHIKV proteins Inactivated by formalin NA NA NA NA NA NA https://link.springer.com/chapter/10.1007/82_2019_175 NA
10412 Tween/Ether-CHIKV Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Inactivated Preclinical NA NA NA NA NA NA NA CHIKV proteins Inactivated by Tween 80 and ether NA NA NA NA NA NA https://link.springer.com/chapter/10.1007/82_2019_175 NA
10413 rCHIKVE1/E2 Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Subunit vaccine Preclinical NA NA NA NA NA NA NA Recombinant E1 and E2 proteins NA NA NA NA NA NA NA https://link.springer.com/chapter/10.1007/82_2019_175 NA
10414 rE2p Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Subunit vaccine Preclinical NA NA NA NA NA NA NA Recombinant E2 protein NA NA NA NA NA NA NA https://link.springer.com/chapter/10.1007/82_2019_175 NA
10415 p181/25-7 Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA DNA based vaccine Preclinical NA NA NA NA NA NA NA CHIKV strain 181/25 NA NA NA NA NA NA NA https://link.springer.com/chapter/10.1007/82_2019_175 NA
10416 CVM1-IgG Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA DNA based vaccine Preclinical NA NA NA NA NA NA NA E2-reactive monoclonal antibody NA NA NA NA NA NA NA https://link.springer.com/chapter/10.1007/82_2019_175 NA
10417 pVax1-MCE321 Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA DNA based vaccine Preclinical NA NA NA NA NA NA NA CHIKV envelope proteins (E1, E2, and E3) NA NA NA NA NA NA NA https://link.springer.com/chapter/10.1007/82_2019_175 NA
10418 DREP-Env Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA DNA based vaccine Preclinical NA NA NA NA NA Intradermal NA DNA replicon encoding nsP and E1, E2, E3 NA NA NA NA NA NA NA https://link.springer.com/chapter/10.1007/82_2019_175 NA